SCHEMBL1204670

SCHEMBL1204670

O=P(c1ccccn1)(c1ccccn1)c1ccccn1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.58
CA2 P00918 1/20 0.58
LMNA P02545 2/20 0.43
P4HTM Q9NXG6 2/20 0.43
KDM4E B2RXH2 2/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
CCR1 P32246 1/20 0.43
CCR5 P51681 1/20 0.43
CCR8 P51685 1/20 0.43
METAP1 P53582 1/20 0.43
BLM P54132 1/20 0.43
HIF1A Q16665 1/20 0.43
DOHH Q9BU89 1/20 0.43
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
ALDH1A1 P00352 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14020767 0.91 CA1 (0.50) CA1CA2LMNAP4HTMKDM4E
SCHEMBL14020799 0.88 CA1 (0.52) CA1CA2LMNAP4HTMKDM4E
SCHEMBL5835237 0.86 CA2 (0.50) CA1CA2LMNAP4HTMKDM4E
SCHEMBL29539386 0.86 CA2 (0.50) CA1CA2LMNAP4HTMKDM4E
SCHEMBL19019641 0.86 CA2 (0.50) CA1CA2LMNAP4HTMKDM4E
SCHEMBL22990157 0.85 CA1 (0.45) CA1CA2LMNAP4HTMKDM4E
SCHEMBL22990166 0.85 CA1 (0.45) CA1CA2LMNAP4HTMKDM4E
SCHEMBL14020768 0.85 CA1 (0.45) CA1CA2LMNAP4HTMKDM4E
Lithium SCHEMBL31194789 0.84 CA2 (0.48) CA1CA2LMNAP4HTMKDM4E
Hydrochloric Acid SCHEMBL19019639 0.84 CA2 (0.48) CA1CA2LMNAP4HTMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210355378-A9 HETEROCYCLIC COMPOUNDS EXHIBITING THERMALLY ACTIVATED DELAYED FLUORESCENCE (TADF) AND THEIR USE IN ELECTROLUMINESCENT DEVICES UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) 2021-11-18 US disclosed
US-20210047560-A1 HETEROCYCLIC COMPOUNDS EXHIBITING THERMALLY ACTIVATED DELAYED FLUORESCENCE (TADF) AND THEIR USE IN ELECTROLUMINESCENT DEVICES UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) 2021-02-18 US disclosed
US-10490754-B2 Transition metal complexes with tripodal ligands and the use thereof in OLEDs UDC IRELAND LIMITED (IE) 2019-11-26 US disclosed
US-20170194576-A1 Transition Metal Complexes with Tripodal Ligands and the Use Thereof in OLEDs UDC IRELAND LIMITED (IE) 2017-07-06 US disclosed
US-20170194576-A1 Transition Metal Complexes with Tripodal Ligands and the Use Thereof in OLEDs UDC IRELAND LIMITED (IE) 2017-07-06 US disclosed
EP-2371831-B1 PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND NIPPON SODA CO (JP) 2016-09-07 EP disclosed
US-9133098-B2 Process for producing organolithium compound and process for producing substituted aromatic compound NIPPON SODA CO., LTD. (JP) 2015-09-15 US disclosed
US-20150025276-A1 PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND NIPPON SODA CO., LTD. (JP) 2015-01-22 US disclosed
US-8871970-B2 Process for producing organolithium compound and process for producing substituted aromatic compound NIPPON SODA CO., LTD. (JP) 2014-10-28 US disclosed
US-20130001472-A1 THIN FILM AND COMPOUND USED IN THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-01-03 US disclosed
US-20040016910-A1 Non-toxic corrosion-protection rinses and seals based on rare earth elements DAYTON, UNIVERSITY OF 2004-01-29 US disclosed
US-20040011252-A1 Non-toxic corrosion-protection pigments based on manganese UNIVERSITY OF DAYTON 2004-01-22 US disclosed
US-20030234063-A1 Non-toxic corrosion-protection conversion coats based on cobalt DAYTON, UNIVERSITY OF 2003-12-25 US disclosed
US-20030230363-A1 Non-toxic corrosion-protection rinses and seals based on cobalt UNIVERSITY OF DAYTON 2003-12-18 US disclosed
WO-2003060192-A1 NON-TOXIC CORROSION-PROTECTION RINSES AND SEALS BASED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
WO-2003060191-A2 NON-TOXIC CORROSION-PROTECTION CONVERSION COATINGES ABSED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
WO-2003060019-A1 NON-TOXIC CORROSION PROTECTION PIGMENTS BASED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
US-20020035029-A1 Catalyst for trimerization of ethylene and process for trimerizing ethylene using the catalyst TOSOH CORPORATION (JP) 2002-03-21 US disclosed
US-6337297-B1 CHROMIUM CATALYST FOR TRIMERIZATION OF ETHYLENE WITH MULTIDENTATE LIGAND OR HALOGEN, CARBOXY GROUP TOSOH CORPORATION (JP) 2002-01-08 US disclosed
US-4233251-A PARTIALLY CHLORINATED CYCLOPENTADIENE REACTED WITH CHLORINE IN THE PRESENCE OF A PHOSPHORUS COMPOUND VELSICOL CHEMICAL CORPORATION (US) 1980-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10490754-B2 Transition metal complexes with tripodal ligands and the use thereof in OLEDs TRPM2, OCIAD2, TRPM6 CA1 2967/4885CA2 1518/4885LMNA 1705/4885
US-20210355378-A9 HETEROCYCLIC COMPOUNDS EXHIBITING THERMALLY ACTIVATED DELAYED FLUORESCENCE (TADF) AND THEIR USE IN ELECTROLUMINESCENT DEVICES ETFA, TEAD2, TERF2 CA1 3333/4885CA2 1583/4885LMNA 813/4885
US-20210047560-A1 HETEROCYCLIC COMPOUNDS EXHIBITING THERMALLY ACTIVATED DELAYED FLUORESCENCE (TADF) AND THEIR USE IN ELECTROLUMINESCENT DEVICES ETFA, TEAD2, TERF2 CA1 3333/4885CA2 1583/4885LMNA 813/4885
US-20130001472-A1 THIN FILM AND COMPOUND USED IN THE SAME NR2E3, NR3C1, NR0B2 CA1 952/4885CA2 3062/4885LMNA 2177/4885
US-20170194576-A1 Transition Metal Complexes with Tripodal Ligands and the Use Thereof in OLEDs TRPM2, OCIAD2, TRPM6 CA1 2967/4885CA2 1518/4885LMNA 1705/4885
US-20150025276-A1 PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND C9, TRPA1, PKD1 CA1 614/4885CA2 62/4885LMNA 834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.